You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

MHRA grants marketing authorisation for Novartis’ Pluvicto

Advanced Accelerator Applications – a Novartis company – has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation in Britain for Pluvicto.